Hostname: page-component-5c6d5d7d68-wtssw Total loading time: 0 Render date: 2024-08-27T20:25:48.081Z Has data issue: false hasContentIssue false

Anxiety and subjective assessment of cognitive functions after COVID-19.

Published online by Cambridge University Press:  27 August 2024

T. I. Medvedeva
Affiliation:
Clinical psychology, Federal Stare Budgetary Scientific Institution “Mental Health Research Center”, Moscow, Russian Federation
O. M. Boyko*
Affiliation:
Clinical psychology, Federal Stare Budgetary Scientific Institution “Mental Health Research Center”, Moscow, Russian Federation
S. N. Enikolopov
Affiliation:
Clinical psychology, Federal Stare Budgetary Scientific Institution “Mental Health Research Center”, Moscow, Russian Federation
O. U. Vorontsova
Affiliation:
Clinical psychology, Federal Stare Budgetary Scientific Institution “Mental Health Research Center”, Moscow, Russian Federation
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Wide circulation of the COVID-19 has led to the high occurrence of a longcovid in which the complaints of violations of cognitive functions and affective disorders often occur.

Objectives

The aim of this study was to assess the relation of anxiety and subjective appraisal of the states of cognitive functions.

Methods

The data of 1233 respondents of internet-research who were divided into the four groups according to their COVID-19 status and the level of anxiety. Group 1 (didn’t have COVID before, low level of anxiety) – 689 people (mean age 40,6), group 2 (didn’t have COVID before, High level of anxiety) – 364 people (mean age 39,8), group 3 (had been ill COVID-19, low level of anxiety) – 102 people (mean age 41,2), group 4 (had been ill COVID-19, High level of anxiety) -130 people (mean age 35,5). Methods include the questions about the states of their cognitive functions (attention, memory, working capacity), a question about COVID-19 status. There are the results of comparing the groups that was carried out using the Kruskal-Wallis test. A pairwise comparison was carried out using the Mann-Whitney test for two groups of people who were not ill; two groups who were ill; two groups with a low level of anxiety; two groups with a high level of anxiety. To correct multiple comparisons, the adjusted significance level calculated by the formula (p = 1 - 0,9511/n) was used, which was p=0,017 for 4 pairwise comparisons.

Results

Results are shown in table.

Group 1Group 2Group 3Group 4
Trouble remembering things0,500,990,771,30
(*2)(*1,*4)(*1,*4)(*2,*3)
Feeling low in energy or slowed down0,741,771,232,34
(*2,*3)(*1,*4)(*1,*4)(*2,*3)
Having to do things very slowly to insure correctness0,270,880,311,00
(*2)(*1)(*4)(*3)
Difficulty making decisions0,631,630,821,67
(*2)(*1)(*4)(*3)
Your mind going blank0,341,120,641,36
(*2,*3)(*1)(*1,*4)(*3)
Trouble concentrating0,581,550,721,86
(*2)(*1,*4)(*4)(*2,*3)
Feeling everything is an effort0,431,470,561,81
(*2)(*1,*4)(*4)(*2,*3)

An entry in parentheses such as (2*) means that this group for this parameter statistically significant differs from group 2.

As indicated in the table, respondents with the high level of anxiety have higher levels of the subjective assessment of cognitive functions regardless of their COVID-19 status.

Conclusions

A possible explanation may be the disorganizing effect of anxiety on the cognitive functions. When combined with possible organic disorders caused by the transferred COVID-19, the most marked indicators of cognitive decline are observed. An effective rehabilitation of cognitive functions after COVID-19 requires to diagnose the level of anxiety and to seek psychological and psychiatric assistance for people with a high level of anxiety.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.